Bharat Biotech Launches Typbar-TCV™, world’s first clinically proven typhoid conjugate vaccine for infants 6 months & older and Adults.
The new vaccine brings hope to millions of adults and infants older than 6 months, by protecting against typhoid fever caused by Salmonella typhi, a highly virulent and invasive enteric bacterium.
